Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

[Q]: Paragraph: "Cost data for flibanserin is not provided. Some projection of cost should be available for any drug this far along in Phase III trials – and for which the company has already begun marketing campaigns. If not from the company, then from stock analysts. The story properly quantifies the reported benefits in absolute terms which allows the reader to see that they are small. (Results are described in Quality of Evidence comments.) In an interview a study researcher conceded that the absolute number of women reporting benefit was not large. The story provided statistics on common side effects including daytime sleepiness, dizziness, fatigue, anxiety, dry mouth, nausea and insomnia. These side effects resulted in 15% of those taking flibanserin vs 7% taking placebo withdrawing from the study. The story does a good job of presenting and evaluating the available evidence. Results are presented in absolute terms, for example that just under one third of women taking flibanserin reported improvement in sexual distress/desire compared to approximately one fifth of women taking placebo. In contrast, these results were presented in relative terms by the manufacturer. Except for the headline, "" ‘Female Viagra’ May Treat Low Sexual Desire"", this story avoids disease mongering and notes that ""hypoactive sexual desire disorder"" in women is a controversial diagnosis. The text clarifies that while the popular press is dubbing flibanserin as the ""female Viagra"", it is not similar to Viagra or other drugs to treat erectile dysfunction. Conflicts of interest are disclosed. The story noted that the study researcher interviewed is a paid consultant for the drug manufacturer. An alternative point of view is provided by two independent experts, a psychologist and a sex-therapist. The independent sources comment on the role that personal relationships play in sexual desire and experience which was not addressed or acknowledged by the researchers. The story indicates that an alternative drug called the Intrinsa testosterone patch is available in Europe, but not in the U.S. The story also notes a difference between these dugs; Intrinsa is a hormonal treatment compared to flibanserin which is a non-hormonal. The story indirectly informs that reader that flibanserin is not available by noting that it is in phase III clinical trials and that the manufacturer is seeking FDA approval (despite early direct to consumer marketing campaigns). The story makes it fairly clear that this is a new treatment – also for a new and controversial diagnosis. The story was apparently based on research presented in abstract form at the annual clinical meeting of the American College of Gynecologists and Obstetricians, although this information has not been published in independently, peer-referred scientific journals. There is no direct evidence that it relied largely on a news release. In fact, the use of interviews with independent experts makes it clear that independent reporting took place." Claim: ‘Female Viagra’ May Treat Low Sexual Desire
[A]: "This story reports on a investigational drug, flibanserin, that is being developed to treat what is a controversial diagnosis called ""hypoactive sexual desire"" in women. The popular press has dubbed this drug ""Female Viagra"" despite that fact that it has few similarities to drugs that treat erectile dysfunction. Preliminary research examining the drug’s efficacy in treating sexual distress and/or low sexual desire were presented at the May 2010 annual clinical meeting of the American College of Obstetricians and Gynecologists (ACOG). To place the story in context, previous reports from the manufacturer claimed that flibanserin resulted in ""clinically significant"" improvement in the number of sexually satisfying events reported by women taking the drug vs. those taking placebo, an absolute difference of 0.7 events per month. The story was detailed and did a good job of presenting information in absolute terms so that the reader could clearly see that reported benefits were small and of unknown clinical significance. Good reminders that this is a controversial diagnosis and that ""some experts see it as the medicalization of what is for many women a relationship issue."""


[Q]: Paragraph: The Wichita Eagle reports that the Kansas Department of Health and Environment says two deaths in the state have already been directly attributed to influenza as of Monday. Pneumonia has been the direct cause of death in another 38 deaths, and the flu or pneumonia has been contributing factors in an additional 132 deaths. In last week’s KDHE flu report for Kansas, there were 101 outpatient visits for influenza-like illnesses. The newborn to 4 years old age group had 29 reported cases for the first week of the flu season. Flu shots are generally recommended for anyone age 6 months and older. Flu symptoms include a fever, body aches, chills, tiredness, cough and headache. ___ Information from: The Wichita (Kan.) Eagle, http://www.kansas.com Claim: Kansas records its first flu death of the season.
[A]: Health officials say Kansas has recorded its first flu deaths of the season.


[Q]: Paragraph: Despite a 25-year-old international ban on most international elephant ivory trade, poachers are illegally slaughtering elephants by the thousands for their tusks and wildlife advocates blame the remaining ivory trade. In the United States, regulations against trading in ivory are tightening. The state of New York has adopted a near total ban and the Obama administration is tightening federal rules. This is unfair, say people like Defrin, whose gallery sells costly figurines, vases and other ivory curios. Such antiques contain ivory taken from elephants in the distant past, sometimes centuries ago, and should not be subject to sales restrictions, they say. Defrin said regulations already in place have damaged his business, drying up European demand for his goods and restricting import of ivory. “They’ve basically ruined the collective antique trade,” he said. “Is this really something that will stop poor African people from killing elephants?”  Yes, say wildlife advocates and regulators. They say an “antique loophole” in existing rules sometimes allows new ivory to be disguised as old, fueling global demand for tusks and keeping illegal poaching profitable. “This poaching crisis in Africa is being driven by demand for ivory,” said Laura Noguchi, a biologist with the U.S. Fish and Wildlife Service. With the U.S. Congress back this month after a summer break, a fight over ivory trade regulation is taking shape. It will not be a top priority for lawmakers faced with other urgent decisions. But it may get attention due to the involvement of the National Rifle Association. One of Washington’s most powerful special interest groups, the NRA is advocating for the interests of gun enthusiasts with ivory-decorated weapons. Alaska’s Don Young and California’s Ken Calvert, both Republican representatives, are offering legislation to soften  Obama administration restrictions issued over the last year. “The administration’s ivory rule is well-intentioned, but was not crafted carefully enough to account for law-abiding Americans who may possess legally obtained products containing ivory,” Calvert told Reuters in a statement. Ivory has been used for hundreds of years in manufacturing items such as the tips of bows for stringed instruments, piano keys, decorative items for the home, and importantly, for ornamental inlays in rifle and shotgun stocks and handgun grips. Even though the ivory trade is largely curbed globally under the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES), an estimated 100,000 African elephants were killed by poachers between 2010 and 2012, according to a study last year by the National Academy of Sciences. Much of the demand for ivory comes from Asia. In China, a growing affluent class has increasingly sought ivory as an ornamental item. Some experts have reported that speculators in eastern Asia are stockpiling raw ivory, hoping it will fetch higher prices in the future. The U.S. Fish and Wildlife Service, which regulates ivory sales on a federal level, said the United States is a “significant market” for ivory, though it had no detailed estimates for ivory trading in the country. The agency issued a director’s order last year prohibiting commercial import of all ivory, without exception, and clarified other limits on ivory exports. The agency followed up that order with a proposal in July that would further limit exports of ivory to legally qualified antiques. The proposal would offer an exemption allowing the sale of certain manufactured items that contain less than 200 grams (7 ounces) of ivory, a move the service said should include most firearms and musical instruments. New York state outlawed the sale of ivory last year, offering exceptions only for items proven to be antique and containing only a small amount of ivory. Earlier this month, California’s legislature approved a similar measure. Just how much new illegal ivory may be “laundered” as antique is unclear. A study of ivory for sale in Los Angeles in 2014 commissioned by the Natural Resources Defense Council, an environmental group, found that up to 90 percent of the ivory surveyed may have been illegal under California law, and as much as 60 percent may have been prohibited under federal law. The study’s author, Daniel Stiles, cautioned that determining the age of ivory by visual examination is subjective. The only way to firmly date ivory is based on carbon dating and DNA tests, which are costly and require cutting into the ivory. Wildlife groups have applauded the Obama administration’s actions and are seeking more bans at the state level on even the sale of antique ivory similar to New York’s statute. “The more we can eliminate legal markets in ivory, the more difficult it becomes to sell ivory illegally,” said Andrew Wetzler, director of the wildlife program for the Natural Resources Defense Council. Claim: Push to save African elephants stirs U.S. clash over antique ivory trade.
[A]:
The ornate ivory statues and carvings sold in Scott Defrin’s New York gallery date from the 17th and 18th centuries, but the antique dealer’s business is being upended by a 21st century fight over saving the African elephant.